Opko Health Inc. (OPK) Cut to Neutral at J P Morgan Chase & Co

J P Morgan Chase & Co lowered shares of Opko Health Inc. (AMEX:OPK) from an overweight rating to a neutral rating in a report published on Thursday morning, StockTargetPrices.com reports.

Separately, Jefferies Group LLC reiterated a hold rating and set a $8.00 price objective on shares of Opko Health in a research report on Tuesday, June 13th.

Opko Health (AMEX OPK) opened at 5.97 on Thursday. The firm’s 50 day moving average price is $6.21 and its 200-day moving average price is $6.88. The stock’s market cap is $3.34 billion. Opko Health has a 52 week low of $5.85 and a 52 week high of $12.15.

TRADEMARK VIOLATION WARNING: “Opko Health Inc. (OPK) Cut to Neutral at J P Morgan Chase & Co” was posted by Transcript Daily and is the property of of Transcript Daily. If you are viewing this article on another website, it was stolen and republished in violation of US & international copyright and trademark laws. The original version of this article can be read at https://transcriptdaily.com/2017/09/17/opko-health-inc-opk-cut-to-neutral-at-j-p-morgan-chase-co.html.

Opko Health Company Profile

OPKO Health, Inc is a healthcare company. Its segments include Pharmaceutical, Diagnostics and Corporate. Pharmaceutical consists of the pharmaceutical operations in Chile, Mexico, Ireland, Israel and Spain and its pharmaceutical research and development operations. Diagnostics consists of the clinical laboratory operations in Bio-Reference Laboratories (Bio-Reference) and its point-of-care operations.

Stock Target Prices

Receive News & Ratings for Opko Health Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Opko Health Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply